PHILADELPHIA, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Brainsway, a leading developer of a breakthrough technology for the treatment of brain disorders, today announced a partnership with NeuroMed TMS Centers, a network of neuropsychiatric clinics, to make its Deep Transcranial Magnetic Stimulation (Deep TMS) systems more widely available. Physicians now have the option to refer patients to NeuroMed clinics for Deep TMS treatment, or they can work with NeuroMed to provide Deep TMS in their own offices. NeuroMed currently has clinics in Nashville, Tennessee and will be expanding within the state to Knoxville and Chattanooga, as well as into Atlanta, Georgia over the coming months.
"We are thrilled to partner with NeuroMed, a dedicated TMS provider, as we continue to expand our reach in the U.S. market,” said Guy Ezekiel, MD, president and chief executive officer of Brainsway. “Partnering with NeuroMed and its impressive network of psychiatrists allows us to further increase patient access across the country, building on the thousands of patients who have experienced the relief Deep TMS provides and testimonials from physicians and patients alike.”
Brainsway has been expanding its operations in the American market to provide physicians with the Deep TMS technology. Deep TMS uses Brainsway’s patented technology to non-invasively pulse magnetic waves into the brain to treat the areas that can cause depression.
"Brainsway’s system will allow us to improve the quality of care provided to our patients, as its patented technology raises the bar for depression care, shortening the duration of treatments and improving overall patient outcomes,” said Dr. Charles Ihrig, chief executive officer of NeuroMed.
Dr. Daniel Barton, medical director of NeuroMed, said, “As medical practitioners, we owe it to our patients to provide the most effective therapies out there, and we are confident that offering Deep TMS will enhance the treatment of depression and other brain disorders.”
As part of the agreement, NeuroMed will purchase a minimum of ten systems over the next three years, in addition to the two systems it currently owns.
Brainsway Ltd. is dedicated to the development and marketing of Deep TMS (Transcranial Magnetic Stimulation) systems for the treatment of brain disorders. Brainsway’s unique therapy is based on patents filed by the National Institutes of Health (NIH) and by the company. Brainsway holds the exclusive license from the NIH for the patent and technology. Brainsway's Deep TMS therapy has been cleared by the FDA for treatment of depression patients who do not respond to any number of medication treatments in the current depressive episode. The treatment has been enthusiastically received by the international academic community, with 60 clinical trials conducted in major institutions worldwide. For more information, please visit www.brainsway.com.
About NeuroMed TMS Centers, LLC
NeuroMed TMS Centers is a newly formed entity developed by Dr. Charles Ihrig and Dr. Daniel Barton. Dr. Ihrig is a psychologist with an extensive background in mental health business development, and Dr. Barton is a board certified psychiatrist in child and adolescent psychiatry, as well as adult psychiatry. Dr. Barton was an early adopter of TMS technology and brings years of clinical experience to the program. NeuroMed is based in Nashville but has positioned itself, with the help of a group of investors, to be a regional provider of TMS services.
Media Contact Deana Cardona firstname.lastname@example.org (201) 465-8032